MeSH D006073 - gout
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Abbott Biotherapeutics | Allopurinol | Lopurin |  | 1982-01-01 |  |  |
| Able Laboratories | Naproxen | Naproxen |  | 2003-08-22 |  |  |
| Accord Healthcare | Allopurinol | Allopurinol |  | 2013-05-06 |  |  |
| Ajanta Pharma | Naproxen, Esomeprazole strontium | Naproxen Esomeprazole Magnesium |  | 2022-10-06 |  |  |
| Alembic Pharmaceuticals | Febuxostat | Febuxostat |  | 2019-07-01 |  |  |
| Alkem Laboratories | Colchicine | Colchicine |  | 2019-02-08 |  |  |
| Febuxostat | Febuxostat |  | 2021-12-07 |  |  | |
| Allergan | Aspirin, Caffeine, Codeine, Butalbital | Fiorinal W/codeine |  | 1990-10-26 |  |  |
| Allopurinol | Allopurinol |  | 1984-11-16 |  |  | |
| Aspirin, Caffeine, Codeine, Butalbital | Butalbital, Aspirin, Caffeine, Codeine |  | 1995-08-31 |  |  | |
| Colchicine, Probenecid | Col-probenecid |  | 1982-01-01 |  |  | |
| Colchicine | Colchicine |  | 2019-07-31 |  |  | |
| Naproxen | Naproxen |  | 1995-02-10 |  |  | |
| Naproxen, Esomeprazole strontium | Naproxen Esomeprazole Magnesium |  | 2022-08-24 |  |  | |
| Colchicine, Probenecid | Proben-c |  | 1982-01-01 |  |  | |
| Probenecid | Probenecid |  | 1983-03-29 |  |  | |
| Colchicine, Probenecid | Probenecid W/ Colchicine |  | 1982-01-01 |  |  |
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
56%9/16
Phase 2
57%17/30
Phase 3
71%24/34
Approved: 15Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use